Agenda
Detailed agenda TBA. Please check back soon!
Keynote Speakers
Swiss Federal Institute of Technology Lausanne (EFPL), Switzerland, Inst. of Cancer Research, London, UK
Dana-Farber Cancer Institute
Boston, MA, USA
Confirmed Speakers & Chairs
University of Edinburgh, Scotland
European Institute of Oncology, University of Milan, Italy
University of Utah
Salt Lake City, UT, USA
Weill Cornell Med./New York-Presbyterian Hosp., NY, USA
Fred Hutchinson Cancer Center, Seattle, WA, USA
UMC Utrecht,
Netherlands
Katholieke Universiteit Leuven,
Leuven, Belgium
Lobular Breast Cancer Ireland
Katholieke Universiteit Leuven,
Leuven, Belgium
University of Pittsburgh, Pittsburgh, PA, US
University of Texas Southwestern,
Dallas, TX, USA
Dana-Farber Cancer Institute,
Boston, USA
Charité-Universitätsmedizin, Berlin, Germany
UMC Utrecht,
Netherlands
Institute for Precision Medicine, University of Pittsburgh & UPMC, Pittsburgh, PA, USA
Fred Hutchinson Cancer Center,
Seattle, WA, USA
Dana-Farber Cancer Institute,
Boston, MA, USA
University of Texas MD Anderson Cancer Center,
Houston, TX, USA
UPMC Hillman Cancer Center; Magee-Womens Research Institute, Pittsburgh, PA, USA
Independent ILC advocate; Breast Cancer Care & Research Fund (BCCRF)
Memorial Sloan Kettering Cancer Center, NY, USA
University of Colorado Denver, Anschutz Medical Campus,
Denver, CO, USA
Foundation Medicine,
Boston, USA
Lobular Breast Cancer UK (LBCUK)
Hoag Family Cancer Institute, University of Southern, California, USA
Katholieke Universiteit Leuven,
Leuven, Belgium
Memorial Sloan Kettering Cancer Center,
NYC, NY, USA
Royal College of Surgeons in Ireland (RCSI),
Dublin, Ireland
Dwek Inst. for Cancer Therapy Research, Weizmann Institute of Science, Rehovot, Israel